Cramer says Vertex has a drug that may address the 'largest market opportunity in the world' – NBC10 Philadelphia
CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.
Stay updated with breaking news from Cramer Charitable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.
CNBC’s Jim Cramer sees opportunity in cybersecurity stocks including Palo Alto Networks, which his Charitable Trust owns.
CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.
Shares of Palo Alto Networks (PANW) have lately been "just kind of unstoppable," CNBC's Jim Cramer said Monday. "Those who are looking for bull markets — of…
CNBC’s Jim Cramer sees opportunity in cybersecurity stocks including Palo Alto Networks, which his Charitable Trust owns.